3//SEC Filing
Harel Insurance Co LTD 3
Accession 0001178913-20-001359
CIK 0001797336other
Filed
May 6, 8:00 PM ET
Accepted
May 7, 8:38 PM ET
Size
9.7 KB
Accession
0001178913-20-001359
Insider Transaction Report
Form 3
Harel Insurance Co LTD
10% Owner
Holdings
- 1,094,385(indirect: See footnote)
Common Stock, par value $0.01 per share
- (indirect: See footnote)
Series A Preferred Stock, par value $0.01 per share
→ Common Stock (307,692 underlying) - (indirect: See footnote)
Series B Preferred Stock, par value $0.01 per share
→ Common Stock (211,757 underlying)
Holdings
- 1,094,385(indirect: See footnote)
Common Stock, par value $0.01 per share
- (indirect: See footnote)
Series A Preferred Stock, par value $0.01 per share
→ Common Stock (307,692 underlying) - (indirect: See footnote)
Series B Preferred Stock, par value $0.01 per share
→ Common Stock (211,757 underlying)
Footnotes (3)
- [F1]Share numbers in this Statement give effect to the reverse split of each share of the Issuer's Common Stock into 0.5 shares of Common Stock, which will be effective for the shares of Series A Preferred Stock and Series B Preferred Stock (together, the "Preferred Stock") upon their conversion into Common Stock upon the closing of the Issuer's initial public offering.
- [F2]All of the shares of Common Stock and Preferred Stock reported in this Statement are directly held by Harel Insurance Company Ltd. ("Harel Insurance"), a wholly owned subsidiary of Harel Insurance Investments & Financial Services Ltd. ("Harel Holdings"), for Harel Insurance's own account. While Harel Insurance operates under independent management and makes independent voting and investment decisions, Harel Holdings may be deemed, by virtue of its ownership of Harel Insurance, to both beneficially own and have a pecuniary interest in all shares presently directly owned by Harel Insurance.
- [F3]The Preferred Stock have no expiration date and are convertible at any time at the election of the holder without payment of further consideration. Each share of Preferred Stock will automatically convert into one share of Common Stock upon the closing of the Issuer's initial public offering.
Documents
Issuer
Ayala Pharmaceuticals, Inc.
CIK 0001797336
Entity typeother
Related Parties
1- filerCIK 0001666482
Filing Metadata
- Form type
- 3
- Filed
- May 6, 8:00 PM ET
- Accepted
- May 7, 8:38 PM ET
- Size
- 9.7 KB